Preparation and antimicrobial activity of gelatin microparticles containing propolis against oral pathogens

Drug Development and Industrial Pharmacy
M L BruschiM P D Gremião

Abstract

Gelatin microparticles containing propolis ethanolic extractive solution were prepared by spray-drying technique. Particles with regular morphology, mean diameter ranging of 2.27 microm to 2.48 microm, and good entrapment efficiency for propolis were obtained. The in vitro antimicrobial activity of microparticles was evaluated against microorganisms of oral importance (Enterococcus faecalis, Streptococcus salivarius, Streptococcus sanguinis, Streptococcus mitis, Streptococcus mutans, Streptococcus sobrinus, Candida albicans, and Lactobacillus casei). The utilized techniques were diffusion in agar and determination of minimum inhibitory concentration. The choice of the method to evaluate the antimicrobial activity of microparticles showed be very important. The microparticles displayed activity against all tested strains of similar way to the propolis, showing greater activity against the strains of E. salivarius, S. sanguinis, S. mitis, and C. albicans.

References

Mar 1, 1992·Annals of the Rheumatic Diseases·H A Capell, M Brzeski
Mar 1, 1984·Journal of Dental Research·R J Gibbons
Feb 28, 1998·Current Microbiology·Y K ParkP L Rosalen
Jul 3, 1998·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·G A Burdock
Jun 11, 1999·Journal of Ethnopharmacology·A KujumgievS Popov
Jan 7, 2000·Journal of Ethnopharmacology·M I Nieva MorenoA R Sampietro
Jul 25, 2000·Journal of Ethnopharmacology·M I MorenoM A Vattuone
Oct 12, 2000·Journal of Ethnopharmacology·J M SforcinS R Funari
Jun 8, 2001·Journal of Ethnopharmacology·M I IslaM A Vattuone
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
Dec 18, 2001·Phytotherapy Research : PTR·A H BanskotaS Kadota
Mar 14, 2002·Journal of Ethnopharmacology·F A SantosF C Braga
Mar 14, 2002·Journal of Ethnopharmacology·Arjun H BanskotaShigetoshi Kadota
May 15, 2002·Journal of Ethnopharmacology·Yun Seon SongChangbae Jin
Aug 15, 2002·International Journal of Pharmaceutics·S SantoyoM J Blanco-Príeto
Dec 24, 2002·Fitoterapia·P G PiettaA M Pietta
Apr 11, 2003·Journal of Ethnopharmacology·Murat KartalGülaçti Topçu
Sep 16, 2003·International Journal of Pharmaceutics·M L BruschiM P D Gremião
Jul 2, 2004·Planta medica·Eleni Melliou, Ioanna Chinou
Jul 21, 2004·Journal of Ethnopharmacology·L M C SimõesY M Lucisano-Valim
Jun 21, 2005·Journal of Ethnopharmacology·J L Ríos, M C Recio

❮ Previous
Next ❯

Citations

Mar 3, 2010·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Kelen F Dalben-DotaTerezinha I E Svidzinski
Oct 5, 2012·Drug Development and Industrial Pharmacy·Lizziane M B de FranciscoMarcos L Bruschi
May 9, 2009·Journal of Ethnopharmacology·Silvana A LibérioRosane N M Guerra
Sep 3, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Andresa Aparecida BerrettaGustavo Henrique Goldman
Jan 30, 2013·Pharmaceutical Development and Technology·Sabrina Barbosa de Souza FerreiraMarcos Luciano Bruschi
May 25, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Kelen Fátima Dalben DotaMarcos Luciano Bruschi
Dec 7, 2016·Future Microbiology·Fernanda Lourenção BrighentiCristiane Yumi Koga-Ito
Nov 9, 2017·Brazilian Oral Research·Maria Alcionéia Carvalho de OliveiraCristiane Yumi Koga-Ito
Jul 19, 2006·Journal of Physics. Condensed Matter : an Institute of Physics Journal·A O ParryJ M Romero-Enrique
Jun 24, 2008·Phytotherapy Research : PTR·Francisco Carlos GroppoEduardo Dias de Andrade
Jun 21, 2018·Frontiers in Microbiology·Flavia F VeigaTerezinha I E Svidzinski
Feb 14, 2017·Nano Convergence·Julius A Edson, Young Jik Kwon
Dec 31, 2019·Beilstein Journal of Nanotechnology·Sabrina Barbosa de Souza FerreiraMarcos Luciano Bruschi
Sep 24, 2009·Mycopathologia·Andresa Piacezzi NascimentoIzabel Yoko Ito
Feb 25, 2021·Future Microbiology·Maria Ac de OliveiraCristiane Y Koga-Ito
Oct 29, 2021·Phytotherapy Research : PTR·Saba SafarzadehAmirhossein Sahebkar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved